MARKET

OBSV

OBSV

Obseva Sa
NASDAQ
0.1421
-0.0017
-1.18%
After Hours: 0.1451 +0.003 +2.11% 18:45 09/30 EDT
OPEN
0.1500
PREV CLOSE
0.1438
HIGH
0.1500
LOW
0.1400
VOLUME
882.36K
TURNOVER
0
52 WEEK HIGH
3.170
52 WEEK LOW
0.1303
MARKET CAP
12.01M
P/E (TTM)
-0.1823
1D
5D
1M
3M
1Y
5Y
After FDA Regulatory Setback, Penny Stock ObsEva Cuts 70% Of Its Staff
Benzinga · 09/13 13:20
BRIEF-Obseva SA Announces Progress On Restructuring Initiatives
BRIEF-Obseva SA Announces Progress On Restructuring Initiatives
Reuters · 09/13 11:05
ObsEva Announces Progress on Restructuring Initiatives
$7.6 million annual savings expected via reduction-in-force currently underway$6.2 million savings expected from assignment of legacy linzagolix program contracts to Kissei Pharmaceutical Co., Ltd., including $1.7 million of accounts payable assigned to da...
GlobeNewswire · 09/13 11:00
ObsEva to cut 70% of workforce
Swiss biotech ObsEva SA (NASDAQ:OBSV) announced Tuesday that the company’s bo...
Seekingalpha · 09/13 10:53
ObsEva to Cut Workforce by 70%; Moves to End Linzagolix License Deal With Kissei Pharmaceutical
ObsEva to Cut Workforce by 70%; Moves to End Linzagolix License Deal With Kissei Pharmaceutical
MT Newswires · 09/13 06:03
Why DWAC Is Trading Lower By Around 19%; Here Are 32 Stocks Moving Premarket
Gainers First Wave BioPharma, Inc. (NASDAQ: FWBI) shares rose 39.6% to $4.44 in pre-market trading after gaining 7% on Friday.
Benzinga · 09/06 10:41
Why Okta Is Trading Lower By Over 32%, Here Are 58 Stocks Moving In Thursday's Mid-Day Session
Gainers ShiftPixy, Inc. (NASDAQ: PIXY) jumped 94.4% to $27.24. ShiftPixy announced a 1-for-100 reverse stock split.
Benzinga · 09/01 16:47
Why Nutanix Is Trading Higher By 16%; Here Are 33 Stocks Moving Premarket
Gainers Bright Green Corporation (NASDAQ: BGXX) shares rose 63.8% to $2.26 in pre-market trading after gaining around 33% on Wednesday.
Benzinga · 09/01 11:00
More
About OBSV
Obseva SA is a Switzerland-based company active in the pharmaceutical and medical research sector. The Company develops oral compounds to treat women’s reproductive health conditions from conception to birth. Its pipeline includes three product candidates: Linzagolix (OBE2109), an oral gonadotropin-releasing hormone (GnRH) receptor antagonist intended for the treatment of endometriosis (phase 2b of clinical trials) and uterine fibroids (phase 3 of clinical trials); Nolasiban (OBE001), an oral oxytocin receptor antagonist undergoing phase 3 of clinical trials, with the potential to inhibit uterine contractions at the time of embryo transfer, thereby enhancing embryo implantation during assisted reproductive technologies (ART), and OBE022, an oral and selective prostaglandin F2 alpha (PGF2a) receptor antagonist designed to control preterm labor (phase 2a of clinical trials).

Webull offers kinds of Obseva SA stock information, including NASDAQ:OBSV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OBSV stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading OBSV stock methods without spending real money on the virtual paper trading platform.